MedDataX Logo

Ghrelin - A Possible Opportunity to Improve Appetite

NCT00681486 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-08-21

No results posted yet for this study

Summary

The study is designed to evaluate whether ghrelin treatment can improve appetite in weight losing cancer patients.

Conditions

  • Cancer

Interventions

DRUG

Ghrelin

High dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks.

DRUG

Ghrelin

Low dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks.

Sponsors & Collaborators

  • Swedish Cancer Foundation

    collaborator OTHER

  • Medical Research Council

    collaborator OTHER_GOV

  • Göteborg University

    lead OTHER

Principal Investigators

  • Kent Lundholm, MD, prof · Göteborg University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2008-06-30
Completion
2008-07-31

Countries

  • Sweden

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00681486 on ClinicalTrials.gov